FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Clinical trial NCT07446322 · RECRUITING

Trial details

NCT number: NCT07446322
Sponsor: Oncolytics Biotech
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ras-mutated Metastatic Colorectal Cancer mCRC MSS Metastatic Colorectal Cancer

Start date: 2026-04-30
Primary completion: 2027-08-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.